Overview
Decompensated cirrhosis refers to the stage of liver disease characterized by the development of complications such as ascites, spontaneous bacterial peritonitis, hepatic encephalopathy, and gastrointestinal bleeding, indicating significant liver dysfunction 1.Diagnosis
Key Diagnostic Criteria: Presence of ascites, spontaneous bacterial peritonitis, hepatic encephalopathy, or gastrointestinal bleeding 1.
Recommended Tests:
- Liver function tests (ALT, AST, bilirubin, INR)
- Abdominal ultrasound or CT scan to assess liver morphology and ascites
- Paracentesis for ascitic fluid analysis
- Blood cultures if infection suspected
Grading: Use Child-Pugh or MELD scores to assess severity and prognosis 1Management
First-Line Treatments:
- Ascites: Diuretics (spironolactone and/or furosemide) 1
- Spontaneous Bacterial Peritonitis: Intravenous antibiotics (e.g., ceftriaxone, albumin infusion) 12
- Hepatic Encephalopathy: Lactulose, rifaximin 1
- Gastrointestinal Bleeding: Endoscopic intervention, vasopressin, somatostatin analogs 1
Adjunctive Treatments:
- Management of complications with multidisciplinary care, including gastroenterology consultation 1
- Antimicrobial stewardship to address multi-drug resistance concerns 2Special Populations
Comorbidities: Antimicrobial resistance poses significant challenges in managing infections in cirrhotic patients, necessitating careful selection of antibiotics 2Key Recommendations
Gastroenterology consultation improves adherence to quality indicators for managing decompensated cirrhosis (Evidence: Moderate 1)
Implement antimicrobial stewardship programs to address multi-drug resistance in treating infections in cirrhotic patients (Evidence: Moderate 2)
Utilize multidisciplinary care, including specialist consultations, to enhance the quality of care for patients with decompensated cirrhosis (Evidence: Moderate 1)References
1 Gonzalez JJ, DiBattista J, Gomez V, Gonzalez E, Zhang Q, Vaughn VM et al.. Impact of Inpatient Attending Specialty and Gastroenterology Consultation on Quality of Care of Patients Hospitalized with Decompensated Cirrhosis. The American journal of medicine 2021. link
2 Fernández J, Bert F, Nicolas-Chanoine MH. The challenges of multi-drug-resistance in hepatology. Journal of hepatology 2016. link